FDA Drug Application (021590) for FAZACLO ODT by JAZZ PHARMS III

Back to FDA Applications sponsored by JAZZ PHARMS III

Application Number021590
Product Number001
FormTABLET, ORALLY DISINTEGRATING;ORAL
Dosage25MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameFAZACLO ODT
Active IngredientCLOZAPINE

Active IngredientCount
List of drugs with Active Ingredient CLOZAPINE4


Back to FDA Applications sponsored by JAZZ PHARMS III